Arnau Puig-Davi

11PUBLICATIONS
22CO-AUTHORS
Toxicology (incl. clinical toxicology)Memory and attentionCentral nervous systemSensory processes, perception and performanceLinguistic structures (incl. phonology, morphology and syntax)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 06, 2026
Neuropsychiatric Adverse Events Associated With Foslevodopa/Foscarbidopa Continuous Subcutaneous Infusion in Clinical Practice: A Multicenter Study.

|Jun 24, 2026
Practice effects as a dynamic biomarker of early cognitive change in far-from-onset Huntington's disease.

|Mar 31, 2026
Spontaneous speech and language measures as predictive biomarkers of clinically meaningful disease progression and neurodegeneration in Huntington's disease.

Arnau Puig-Davi, Carla Franch-Marti, Lara Caler-Gameiro

|Jun 12, 2025
CSF Biomarker-Based Cognitive Trajectories in Parkinson's Disease-Subjective Cognitive Decline.

Jon Rodriguez-Antiguedad, Arnau Puig-Davi, Iñigo Ruíz-Barrio

|Apr 17, 2025
Early Language Impairment as an Integral Part of the Cognitive Phenotype in Huntington's Disease.

Arnau Puig-Davi, Carla Franch-Marti, Iñigo Ruiz-Barrio

|Feb 11, 2025
A randomized clinical trial to evaluate the efficacy of cognitive rehabilitation and music therapy in mild cognitive impairment in Huntington's disease.

Andrea Moreu-Valls, Arnau Puig-Davi, Saul Martinez-Horta

Pageof 2

Frequent Collaborators

9 joint publications

Saul Martínez-Horta

5 joint publications

Iñigo Ruiz-Barrio

4 joint publications

Frederic Sampedro

4 joint publications

Jon Rodriguez-Antiguedad